Podcasts about neonatal abstinence syndrome

Nurturing Hope: How Hushabye Nursery is Transforming Neonatal Care In this episode of Phoenix Business Radio, host Karen Nowicki interviews Tara Sundem, Executive Director and Founder of Hushabye Nursery, about her journey as a neonatal nurse practitioner and the creation of her nonprofit to support families affected by the opioid crisis. Tara explains how Hushabye […] The post Nurturing Hope: How Hushabye Nursery is Transforming Neonatal Care appeared first on Business RadioX ®.

Are you thinking about domestic infant adoption? This is an interview you must listen to! We talk with adoption medicine pediatrician, Dr. Todd Ochs, about common risk factors you should know about before adopting an infant.In this episode, we cover:Common Risk Factors in Domestic Infant AdoptionLack of prenatal care.Why do expectant moms who are considering making an adoption plan often have limited prenatal care?What is covered in prenatal care and how might a lack of prenatal care impact a baby?PrematurityWhat causes a premature birth?Poor prenatal care?Are expectant moms who are considering making an adoption plan more likely to have a premature birth?What are the risks with a premature birth based on the degree of prematurity?Prenatal exposureAlcoholWhat are some red flags that a mom might have abused alcohol during her pregnancy?Does the degree of impact differ depending on when alcohol was consumed in the pregnancy?What are the long- and short-term impacts of alcohol consumption on a child exposed prenatally?Very often, you will not have a diagnosis of FASD and won't be detected in the hospital post-natally.Resources to help parents of a child exposed to alcohol. Creating a Family has a facilitated interactive training for foster, adoptive, and kinship parents to help recognize kids who may have been prenatally exposed to alcohol or drugs, and best practices for helping this child thrive, on-demand courses, and additional resources on the long- and short-term impacts of prenatal substance exposure – visit the Raising a Child with Prenatal Exposure for find more information. Opioids List of opioid drugs in increasing degree of strengthCodeine.Hydrocodone (Vicodin, Hycodan)Morphine (MS Contin, Kadian)Oxycodone (Oxycontin, Percoset)Hydromorphone (Dilaudid)HeroinMethadone, SuboxoneFentanyl (Duragesic)Does the degree of impact differ depending on when in the pregnancy the opioid was used?Does the degree of long-term impact differ depending on whether the baby was born dependent or with a diagnosis of Neonatal Abstinence Syndrome?What are the long- and short-term impacts of opioid exposure on a child exposed prenatally?Does the impact differ depending on what drug was involved or whether it was a legal or illegal drug?Methamphetamine CocaineMarijuanaHallucinogens, including EcstasyMental Health IssuesWhat is the genetic connection for the following mental health disorders? How heritable are these mental illnesses?Anxiety disorders, including panic disorder, obsessive-compulsive disorder, and phobias.Depression, bipolar disorder, and other mood disorders.Personality disorders (antisocial, borderline, narcissistic, obsessive-compulsive)Psychotic disorders, including schizophreniaADHDAutistic Spectrum DisordersLegal Risk FactorsMost often in domestic infant adoption, the primary legal risk factor is an unknown or unidentified birth fatherControlled by state lawWork with your agency or attorney to understand the risk and what must be done to reduce your risk.Please review RateThisPodcast.com/creatingafamilySupport the showPlease leave us a rating or review RateThisPodcast.com/creatingafamily

Today we give you our third pediatric clinical case with Dr. Sakina Butt. Sakina is a neuropsychologist and the neuropsych postdoctoral fellowship training director at Johns Hopkins All Children's Hospital; she is board certified in clinical neuropsychology and in the pediatric subspecialty.  For this case, Sakina talks about a toddler with neonatal abstinence syndrome whom she saw for a neuropsychological evaluation. Just like for the first two cases with Sakina we found this to be an interesting window into a very unique world of neuropsychology, working with very young children. It's well worth it for all of us to consider how to measure brain behavior relationships and promote healthy development in young brains. Show notes are available at www.NavNeuro.com/137 _________________ If you'd like to support the show, here are a few easy ways: 1) Get APA-approved CE credits for listening to select episodes: www.NavNeuro.com/INS  2) Tell your friends and colleagues about it 3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 4) Check out our book Becoming a Neuropsychologist, and leave it an Amazon rating   Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners' own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]

In the first episode of season 3, Dr. U. Grant Baldwin, DBH, Director of the Doctor of Behavioral Health program at Cummings Graduate Institute for Behavioral Health Studies, explores Neonatal Nursing with a focus on Neonatal Abstinence Syndrome, and the critical need for integrated healthcare for infants and families. Panelists include: Tara Sundem, NNP, is a board-certified Neonatal Nurse Practitioner with more than 30 years of experience in neonatal intensive care. She was a frontline worker in the growing opiate epidemic, caring for the most innocent of its victims: Newborns suffering through opiate withdrawal-Neonatal Abstinence Syndrome (NAS). Her passion to transform the healthcare experience for them and their families led her to found Hushabye Nursery, an Arizona non-profit dedicated to caring for opiate-exposed newborns in their first few weeks of life. The 12-bed inpatient nursery opened its doors and its arms to these babies and their mothers in November 2020. Under Tara's leadership as Executive Director, Hushabye Nursery has grown from an idea to ""save the babies"" in 2016, to a unique model of care for this underserved population that focuses on the family unit, both prenatal and postnatal. Recognized as an industry leader on NAS, Tara has presented several community events on the topic. She received the 2021 Phoenix Business Journal Health Care Hero Award for Nursing and 12 News Miracle Makers Award in 2021. She hold a Master of Science from Arizona State University and is a member of the National Association of Neonatal Nurses, the Academy of Neonatal Nurses, and the Neonatal Nurse Practitioners of AZ. Tara lives in Gilbert with her husband, two sons and their dog. --- Support this podcast: https://podcasters.spotify.com/pod/show/disruptors-at-work/support

In a world where the intricacies of our legal system intersect with the heart-wrenching struggles of society's most vulnerable, emerges a remarkable individual whose unwavering dedication knows no bounds. Join us for an exceptionally heartfelt episode of the Heart of Law as our compassionate host, Mirena Umizaj introduces us to prominent Attorney Steve New, a founding member of Stephen New & Associates. Together, they embark on a poignant exploration to uncover the raw realities behind society's two profound wounds: the heart-rending cases of Neonatal Abstinence Syndrome (NAS) and the harrowing conditions within our prison system.  At the heart of today's episode stands a legal luminary who has been a cherished friend of our host, Mirena Umizaj, for more than a decade. With a remarkable career spanning 25 years, Attorney Steve New has championed justice in various legal domains, from catastrophic and wrongful death cases to mass environmental damage and employment discrimination. However, what truly sets him apart is his fearless pursuit of justice in civil rights litigation, confronting the government and state of West Virginia to expose inhumane prison conditions while passionately advocating for babies born with NAS, a cause close to his heart since 2018. His unwavering commitment to these endeavors is exemplified by his impressive track record, having tried over 60 cases to jury verdict and making 8 appearances before the West Virginia Supreme Court of Appeals.  As Mirena and Attorney Steve New embark on their enlightening conversation, the harsh realities of West Virginia's battle with the opioid epidemic come to the forefront, revealing the innocent victims caught in the crossfire. With heartfelt passion, Attorney Steve New reflects on his experience representing NAS cases, powerfully emphasizing, "There is no more innocent victim in this than addicted babies." Within this contemplation, he eloquently sheds light on the intricate challenges in substantiating these highly specialized cases and addresses the heart-wrenching scarcity of support for afflicted families. As the conversation deepens, Attorney Steve New provides insights into the recent proceedings, maintaining an unwavering hope for the appeal despite the disheartening ruling by the West Virginia Mass Litigation Panel, firmly believing that "no cause is truly lost" as he knows that ultimately, "some court is going to hear the voices of these children and care."  Transitioning the conversation, Mirena prompts Attorney Steve New to delve into the origins of his involvement in the Southern Regional Jail cases in West Virginia. He shares that his profound connection with these cases began in early 2022, ignited by the impactful stories he came across, with the tragic case of Quantez Burks standing out prominently among them. Deeply appalled by the systemic issues at hand, Attorney Steve New, alongside his dedicated team, embarked on a relentless mission for justice, filing a lawsuit and subsequently pursuing a class certification on behalf of an astonishing 17,000 inmates. Their work is a testament to the pervasive challenges of overcrowding, understaffing, and deferred maintenance within West Virginia's correctional system, symbolizing a collective effort to rectify these injustices and provide relief for countless individuals who have suffered in silence.  As the conversation concludes, Attorney Steve New unveils his broader vision to Mirena, reaching beyond West Virginia to ignite a nationwide movement for prison reform with the hope of "turning the tide" on harsh conditions and inspiring a change in public sentiment. He emphasizes that the key to achieving this lies in sharing the stories of those affected and fostering collaboration among like-minded individuals and groups. With eager anticipation for the forthcoming October class certification hearing, Mirena extends a heartfelt invitation to all who resonate with the cause to step forward and actively participate in the conversation, ensuring that the vision for change continues to grow.

Are you expecting the placement of a newborn? Don't miss our conversation about the latest information on baby care with Kristen O'Dell, a board-certified Family Nurse Practitioner with almost two decades of working with over 10,000 newborns and their families in her hospital practice of Neonatology and Newborn Medicine.In this episode, we cover:FeedingThe vast majority of adoptive parents will bottle-feed their baby. How to choose a formula.Is liquid or dry formula better for the baby?How to sterilize the dry formula?Do you need to sterilize bottles?What type of bottle is best?Does the bottle type differ if the baby is born premature or has Neonatal Abstinence Syndrome?Does the temperature of the formula matter?Can you make the bottles up once a day, or do you have to make it fresh for each feeding?When should you consider a specialized formula, and what options do you have?How often should a baby eat?Other feeding options: adoptive mother induce lactation to breastfeed; donated breast milk.How do you know if your baby is getting enough food?If your baby spits up a lot, when should you worry that they aren't getting enough food?When to introduce solid food? SleepWhat is a typical wake/sleep pattern for a newborn?When should you expect your baby to sleep for 5-6 hours?Is the wake/sleep cycle affected by prematurity or Neonatal Abstinence Syndrome (NAS)?At what point can you start trying to get your baby to not wake up many times for a feeding at night?Will introducing solid food, even if watered down, help your baby sleep through the night?How can you establish healthy sleeping habits for your baby?When do most babies start sleeping through the night and what is “sleeping through the night”—how much sleep?Safe sleep practices: sleeping on the back, no pillows, blankets, bumpers, stuffed animalsSleep training PoopHow often should babies poop? What is normal?What does the typical healthy newborn baby poop look like?How do you know if there is a problem?How can you tell if your baby is constipated? And what should you do?What type of diaper is best?What type of baby wipes are best?How to treat diaper rash?How can you tell if your baby has a yeast diaper rash?What is colic?How do you treat colic?What is the current thinking on circumcision?Tips for new parents.Free Resource Guide from New Mommy GuruThis podcast is produced by www.CreatingaFamily.org. We are a national non-profit with the mission to strengthen and inspire adoptive, foster & kinship parents and the professionals who support them. Creating a Family brings you the following trauma-informed, expert-based content:Weekly podcastsWeekly articles/blog postsResource pages on all aspects of family buildingPlease leave us a rating or review RateThisPodcast.com/creatingafamilySupport the showPlease leave us a rating or review RateThisPodcast.com/creatingafamily

In this episode, we review the high-yield topic of ⁠⁠Neonatal Abstinence Syndrome ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Pediatrics section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets

On this week's episode, Jeff speaks with Shaun Cross. Shaun is an attorney who has practiced corporate law for over 40 years and who is currently serving as the President/CEO of Maddie's Place, a free standing clinic that provides medical care for drug dependent infants and their mothers.In the episode, Shaun shares how Maddie's Place came to be, how the Opioid Crisis is impacting prenatal exposure to drugs & alcohol, and how Maddie's Place is working to make a difference.About Shaun Shaun is a 4th generation native of Eastern Washington and one of 10 Cross lawyers who have practiced law in Washington State over the past 130 years. In addition to his corporate law practice, Shaun has led numerous organizations in the Spokane Region over a 41-year career. For more than 14 years Shaun served as the CEO and Managing Partner of two of the largest law firms in the Region, Lee & Hayes, PC, and Paine Hamblen, LLP. He is known for his community service having served on the Boards of Trustees of Whitworth University, Spokane Chamber, the Spokane Public Facilities District and various non-profits. Shaun and his wife, Kathy, have been married for 45 years and have four adult children.Shaun has served as the Founding Chairman of Maddie's Place since he incorporated Maddie's in March 2018. Fueled by a love for the Spokane Region and for people generally, Shaun has a passion for Maddie's mission to assist babies born dependent on substances and their moms who too often are trapped in a cycle of despair. During his life Shaun has seen the effects of addiction on members of his extended family and some of his closest friends. Shaun sees Maddie's Place as an opportunity to provide love and serve some of the most innocent and helpless in our community.About Maddie's PlaceMaddie's Place is a 501(c)3 non-profit, free-standing recovery nursery for babies experiencing withdrawal due to prenatal substance exposure. They firmly believe that low-intervention, highly nurturing care is the best way to help babies through this difficult time. They also believe that “mom is the best medicine,” and aim to support moms and babies together, encouraging bonding and attachment and alleviating physical symptoms.This major philosophical shift in the care of babies experiencing Neonatal Abstinence Syndrome, or NAS, is evidence-based and leads to greatly improved long-term results. Their method also provides a cost savings of 70-80%, when compared to caring for these babies in the NICU, as well as an even greater reduction in the amount of Morphine required to help a baby through the peak of their symptoms.Supporting early connections and providing nurturing comfort from the beginning results in a happier, healthier baby and a more stable attachment, which changes the trajectory of lives.More Information on Maddie's Place: www.maddiesplace.org

MedLink Neurology Podcast is delighted to feature selected episodes from BrainWaves, courtesy of James E Siegler MD, its originator and host. BrainWaves is an academic audio podcast whose mission is to educate medical providers through clinical cases and topical reviews in neurology, medicine, and the humanities, and episodes originally aired from 2016 to 2021. Originally released: November 9, 2017 With the ongoing opioid crisis, not only those using opiates are affected. There has been an exponential rise in the incidence of neonatal abstinence syndrome--the multiorgan dysfunction experienced by newborns of mothers who are using opioid products and other substances. This week, we discuss the manifestations and ramifications of this disease, with a short commentary on the implications of this global epidemic. Produced by James E Siegler. Music by Little Glass Men, Jason Shaw, and Chris Zabriskie. Voiceover by Erika Mejia. BrainWaves' podcasts and online content are intended for medical education only and should not be used for clinical decision-making. This is no excuse to give your irritable baby opiates in their applesauce. REFERENCES Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S, Alexander ER. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol 1999;149(3):203-13. PMID 9927214 Hudak ML, Tan RC; Committee On Drugs; Committee On Fetus And Newborn; American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics 2012;129(2):e540-60. PMID 22291123 Jarlenski M, Barry CL, Gollust S, Graves AJ, Kennedy-Hendricks A, Kozhimannil K. Polysubstance use among us women of reproductive age who use opioids for nonmedical reasons. Am J Public Health 2017;107(8):1308-10. PMID 28640680 Kocherlakota P. Neonatal abstinence syndrome. Pediatrics 2014;134(2):e547-61. PMID 25070299 McQueen K, Murphy-Oikonen J. Neonatal abstinence syndrome. N Engl J Med 2016;375(25):2468-79. PMID 28002715 Vlahov D, Des Jarlais DC, Goosby E, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol 2001;154(12 Suppl):S70-7. PMID 11744532 Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse 2006;41(6-7):777-813. PMID 16809167  We believe that the principles expressed or implied in the podcast remain valid, but certain details may be superseded by evolving knowledge since the episode's original release date.

Episode 131: Breastfeeding Part 2Lia and Aruna explain some updates given by the American Academy of Pediatrics regarding breastfeeding. Dr. Arreaza adds some comments about breastfeeding. Written by Aruna Sridharan, MS4, and Lia Khachikyan, MS4, Ross University School of Medicine. Comments by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.The motivation for this episode was a recent publication by the American Academy of Pediatrics, on June 27, 2022, titled Policy Statement: Breastfeeding and the Use of Human Milk. During this episode, we included updated information along with other useful material.Duration of breastfeeding:The American Academy of Pediatrics (AAP), World Health Organization (WHO), and Center of Disease Control (CDC) recommend exclusive breastfeeding at least for the first 6 months, after which one can start to introduce complementary pureed foods. The US Department of Agriculture states that initiating complementary foods earlier than 6 months offers no benefit to the baby and can even be associated with a higher risk of overweight or obesity, especially if introduced before 4 months. Mothers are then encouraged to continue breastfeeding for at least one year and can further continue up to 2 years of age or longer - as long as mutually desired by mother and child. This is an update from previous recommendations regarding the duration of breastfeeding until 1 year of age.Composition of human breastmilk:As the sole source of nutrition for infants in the first 6 months of life, breast milk plays a critical role in development. Human milk has a unique composition of proteins, fats, and lactose, as well as vitamins, electrolytes, antimicrobial, anti-inflammatory immunoregulatory agents, and living leukocytes, all of which contribute to the developing immune system of the child. Breast milk is rich in Vitamins B1, B2, and B6, Vitamins C, A, E, Ca, Mg, phosphate, and folate. However, it is low in Vitamins K, D, B12, and iron, therefore supplementation of these nutrients is required. It is important for mothers to consume an adequate and healthy diet for their breastmilk to contain appropriate levels of these nutrients. Water-soluble and Fat-soluble vitamins can be low in breast milk if the mother has a deficiency. Selenium can be low if maternal serum levels are low. Dietary iodine deficiency may also be exacerbated by smoking; iron deficiency; and consumption of large amounts of foods that interfere with the production of thyroid hormones, known as goitrogens, including Brussels sprouts, kale, cabbage, cauliflower, and broccoli. Maternal diet:Mothers should consume iodine-rich foods, such as lean meat, eggs, dairy, beans, and lentils. It is important to choose a variety of whole grains, as well as fruits and vegetables, and continue taking multivitamins. Fun fact: Different foods will change the flavor of your breast milk. This will expose your baby to different tastes, which might help him or her more easily accept solid foods down the road! It is recommended that mothers consume 290 mcg of iodine and 550mg of choline a day. Is there anything that mothers should avoid in their diet?-Limit seafood: Although fish is a good source of protein and lean meat, it contains some mercury, which can be transferred to the baby's diet. High amounts of mercury can have an adverse effect on the baby's brain and nervous system.-Limit caffeine: Also, we know a lot of people love their morning dose of espresso! Low to moderate amounts, equivalent to 2-3 cups of coffee per day, do not adversely affect the infant. However, anything more than around 300 mg of caffeine can cause irritability, poor sleeping patterns, fussiness, and jitteriness. Remember! This also includes sodas, energy drinks, tea, and even chocolate! As a reminder, one cup of coffee can have 95mg of caffeine.Vegan mothers: Vegetarian/vegan mothers may have very limited amounts of vitamin B12 in their bodies, which can result in neurological damage to the baby. Iron levels may also be sparse since plant-based foods only contain non-heme iron, which is less absorbable than heme iron. The American Dietetic Association recommends supplementation of vitamin B12, iron, and other nutrients such as choline, zinc, iodine, or omega-3 fats. Benefits:For the baby: Studies show that exclusively breastfeeding for 6 months decreased rates of neonatal and infant mortality as well as pediatric disorders such as otitis media, diabetes mellitus, obesity, lower respiratory tract disorders, asthma, atopic dermatitis, sudden infant death syndrome (SIDS), severe diarrhea, and inflammatory bowel disease. The longer an infant is breastfed, the greater the protection from certain illnesses and long-term diseases. For the mother: The longer a mother breastfeeds, the greater the benefits to her health as well. Mothers who breastfeed experience a lower risk of hypertension, type 2 diabetes, and breast, ovarian, and endometrial cancers. Contraindications:-Alcohol: Having up to 1 drink per day is not harmful to the baby, especially if the mother waits at least 2 hours before feeding the infant. This allows time for the blood alcohol concentration in the breastmilk to decrease. Consuming more than 2 standard alcoholic drinks daily is highly discouraged.-Tobacco: Cigarette smoking, or the use of nicotine products, is associated with decreased production of milk, shorter lactation time, and an increased risk of SIDS, asthma, and other respiratory illnesses in infants. Therefore, mothers should be strongly encouraged to stop smoking and minimize secondhand exposure. We know it is very difficult for people to quit abruptly. While transitioning to cessation, mothers should be counseled to smoke right after breastfeeding to allow the greatest amount of time for nicotine to exit the body until the next feed. Other cessation alternatives such as the patch or gum can also be used during breastfeeding.Varenicline: No human data is available to assess the risk of infant harm, but it is likely excreted in the milk, no data on the assessment of milk production.-Other substances: Marijuana, opioids, amphetamine, cocaine, and other illicit drugs are contraindicated due to their effects on neurodevelopmental behaviors. If these substances have been used intrapartum or during breastfeeding, it is important to monitor the baby for Neonatal Abstinence Syndrome. Some symptoms include poor weight gain, tremors, high-pitched crying, stuffy nose, poor feeding/sucking, seizures, irritability, poor sleep, vomiting, and diarrhea.-Maternal infections: Breastfeeding is not contraindicated during most maternal infections. Some exceptions include HIV, Human T-cell lymphotropic virus type I or II, untreated brucellosis, Ebola virus, or active Herpetic lesions on the breast. Women with herpetic lesions may breastfeed from the unaffected breast. -Maternal medications: Medications are relatively safe for breastfed babies, but some contraindications include anticancer drugs, oral retinoids, lithium, iodine, and amiodarone. Mothers should go over their medication list with their primary physician.Pregnancy and Lactation Labeling Final Rule (PLLR): Classification of drugs according to their impact on pregnancy and breastfeeding (categories A, B, C, D, X) was started in 1979, but it was stopped in 2015 and replaced by the Pregnancy and Lactation Labeling Final Rule (PLLR). The former categories were replaced with narrative sections and subsections to include: Pregnancy (including labor and delivery), Lactation, and information for Females and Males of Reproductive Potential (pregnancy testing, contraception, infertility).Role of the physician and stigmas:It is well known that breastfeeding can strengthen the bond between the mother and her child. Therefore, when latching becomes a problem, mothers are quick to become discouraged. If this happens, pediatricians should educate the parents that many breastfeeding problems commonly arise between 4-7 days after birth. Sometimes, exclusive or any amount of breastfeeding is not always possible, despite the mother's best intentions. This can understandably cause them to feel a lot of guilt and disappointment as a new mother. Physicians should provide a safe, non-judgmental environment for the parents to openly discuss their difficulties while educating them on proper latching techniques and other alternatives for breastfeeding.Conclusion: Now we conclude our episode number 131 “Breastfeeding Part 2.” Aruna and Lia explained that the American Academy of Pediatrics now recommends continued breastfeeding until 2 years or as long as the mother and the baby desire it. It is important to remember some contraindications such as babies with galactosemia, mothers who are using illicit drugs, and some maternal infections such as HIV, untreated brucellosis, and Ebola virus. This week we thank Hector Arreaza, Aruna Sridharan, and Lia Khachikyan. Audio editing by Adrianne Silva.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________Dror, D. K., & Allen, L. H. (2018, May 29). Overview of Nutrients in Human Milk. PubMed Central (PMC). https://doi.org/10.1093/advances/nmy022.Meek, J. Y., Noble, L., & Breastfeeding, S. O. (2022, July 1). Policy Statement: Breastfeeding and the Use of Human Milk. American Academy of Pediatrics. https://doi.org/10.1542/peds.2022-057988.“Maternal Diet.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 17 May 2022, https://www.cdc.gov/breastfeeding/breastfeeding-special-circumstances/diet-and-micronutrients/maternal-diet.html.Breastfeeding FAQs. Centers for Disease Control and Prevention. https://www.cdc.gov/breastfeeding/faq/index.htm. Accessed February 21, 2023. Butte, Nancy F., and Alison Stuebe. Maternal nutrition during lactation. UpToDate, July 13, 2022. https://www.uptodate.com/contents/maternal-nutrition-during-lactation. Accessed March 6, 2023. Royalty-free music used for this episode: “Gushito - Burn Flow." Downloaded on October 13, 2022, from https://www.videvo.net/

In this episode Nurse Mo talks about neonatal abstinence syndrome (NAS), which occurs when neonates who were exposed to drugs in the womb experience withdrawal after birth. Tune in to learn all about NAS using the Straight A Nursing LATTE method. Click here for show notes and references: Episode 263 Show NotesDid you find this episode helpful? Then I'd love it if you'd rate and review the podcast! And if you're not following the show, add it to your podcast library so you never miss an episode!

Survey: https://bit.ly/feedback_UltraSounds Sanaya and Regina discuss the management of opioid use disorder in pregnancy with Dr. Townsel. 0:44 Dr. Townsel Bio 1:25 Case 1: 29 year old at 6 weeks pregnant inquiring about oxycodone use 4:12 Case 2: 29 year old on buprenorphine treatment during pregnancy 6:24 Case 3: Neonate with tremors, fever after delivery Transcript: bit.ly/Ultrasounds_OUD1 Jansson, L. M., & Wilkie, L. (2022, April 29). Neonatal Abstinence Syndrome. UpToDate. Retrieved November 14, 2022. Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e81–94. Centers for Disease Control and Prevention. (2021, July 21). Treatment for opioid use disorder before, during, and after pregnancy. Centers for Disease Control and Prevention. Seligman, N. S., Rosenthal, E., & Berghella, V. (2021, November 10). Overview of management of opioid use disorder during pregnancy. UpToDate. Whelan PJ, Remski K. Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds. J Neurosci Rural Pract. 2012 Jan;3(1):45-50. Inspira Health. “The EAT, Sleep, Console Method for Infants with Neonatal Abstinence Syndrome.” Inspira Health, 20 Apr. 2022.

In this episode Dr. Gillian Beauchamp sits down with Dr. Lori Devlin to discuss  Neonatal Abstinence Syndrome (NAS), Neonatal Opioid Withdrawal Syndrome (NOWS) and the treatment of NOWS. 

Pediatrician Jane Lyons, MD, joins Hushabye Nursery's Tara Sundem, MS, Executive Director, and Lee Greenfield, CFRE, Chief Development Officer, to talk about Hushabye Nursery and how it support infants with Neonatal Abstinence Syndrome and families. Mother Jessica Ochoa shares her story and how Hushabye supported her newborn.  Hosted and produced by John McElligott. Sponsored by Bahbah Sobers Wealth Management and AT&T FirstNet. Music by Scott Holmes and Broke for Free. The Arizona Physician Podcast is a production of Maricopa County Medical Society. Please join the growing network of physicians. Visit MCMS online.

Dr. Erin Kelty discusses the incidence of neonatal abstinence syndrome in Western Australia from 2003 to 2018 and provides insight on the medications used to treat opioid use disorders that were a substantial driver of NAS. The full text manuscript is available open access at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2678.

In this episode, Dr. Jadene Wong discusses Neonatal Abstinence Syndrome, also  commonly referred to as Neonatal Opioid Withdrawal Syndrome (NOWS), which describes the withdrawal symptoms an infant experiences after exposure to opioids in the uterus. Dr. Wong reviews which factors increase the risk for developing withdrawal, how to diagnose NOWS, and why avoiding bias while maintaining the mother-infant dyad is essential in treatment. Dr. Wong is a Clinical Associate Professor of Pediatrics at Stanford University School of Medicine and Neonatal Hospitalist at Lucile Packard Children's Hospital. She served as the Newborn Clinical Lead on the task force for the joint CMQCC/CPQCC Mother & Baby Substance Exposure Initiative.Learn more about Dr. Wong at https://profiles.stanford.edu/jadene-wong

We're back for EPISODE FREAKIN' 30 BOOKISH BABES! This week, Allie marks the end of her TBR (hell yeah she did that) with a full review of Long Bright River by Liz Moore. *TRIGGER WARNINGS during this review and discussion for drug use/abuse, drug overdose, Neonatal Abstinence Syndrome, child abuse, and homicide.* Meg continues the episode with SPOILER-FREE reviews of The Love Hypothesis by Ali Hazelwood, Twisted Games by Ana Huang, and her opinions on the heavily debated "Miscommunication Trope" in romance novels. Sip on your Liquor Hypothesis cocktail of the week and celebrate 30 episodes of The Bibliofiles with your favorite bookish ladies. Next week we get into the world of Jennifer L. Armentrout's From Blood and Ash series. Happy Reading!

Dr. Nirav Shah, ASTHO President and Director of the Maine Center for Disease Control and Prevention, discusses concerns of workshop participants about the way Emergency Use Authorization (EUA) decisions are communicated; Ericka McGowan, ASTHO's Senior Director of Emerging Infectious Disease, writes a blog article sharing seven things to know about vaccines for pregnant people; Priyanka Surio, ASTHO's Senior Director for Public Health Data Modernization and Informatics, reviews a new report assessing data collection related to Neonatal Abstinence Syndrome; and ASTHO promotes key job openings. The National Academies Webpage: FDA EUA Workshop ASTHO Blog Article: Pregnancy, breastfeeding, and COVID-19 vaccines – Seven things to know ASTHO Report: Strengthening health agencies' Neonatal Abstinence Syndrome surveillance through consensus-driven data standards and practices ASTHO Webpage: Job opportunities in public health and at ASTHO

Join medical student Rilee Racine and Dr. Brian Stansfield, a neonatologist at the Children's Hospital of Georgia discuss Neonatal Opioid Withdrawal Syndrome, also known as NOWS.  After listening to this podcast, learners should be able to: Define neonatal opioid withdrawal syndrome Apply knowledge of signs and symptoms of NOWS to recognize these infants early Demonstrate general understanding of non-pharmacologic vs. pharmacologic management indications Recall the long term effects of NOWS and utilize this information to care for these infants long-term Educate families on clinical symptoms, management, and potential complications of NOWS Peer Review by Dr. Rebecca Yang and Dr. Amy Thompson Free CME Credit (requires sign-in): LINK COMING SOON Thank you for listening to this episode from the Department of Pediatrics at the Medical College of Georgia. If you have any comments, suggestions, or feedback- you can email us at mcgpediatricpodcast@augusta.edu. Remember that all content during this episode is intended for informational and educational purposes only. It should not be used as medical advice to diagnose or treat any particular patient. Clinical vignette cases presented are based on hypothetical patient scenarios. References: Anbalagan S, Mendez MD. Neonatal Abstinence Syndrome. 2020 Oct 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. PMID: 31855342. Armbruster, Debra PhD, APRN-CNP, NNP-BC, CPNP-PC, C-ELBW; Schwirian, Caitlyn PharmD; Mosier, Ashley MS, RN, CNL; Tam, Wai-Yin Mandy PharmD, BCPS, BCCCP; Prusakov, Pavel PharmD, BCPS, BCPPS Neonatal Abstinence Syndrome and Preterm Infants, Advances in Neonatal Care: March 05, 2021 - Volume Publish Ahead of Print - Issue - doi: 10.1097/ANC.0000000000000858 Finnegan LP. Neonatal abstinence syndrome: assessment and pharmacotherapy. In: Nelson N, editor. Current therapy in neonatal-perinatal medicine. 2 ed. Ontario: BC Decker; 1990. Jansson, Lauren M. MD. Neonatal abstinence syndrome. Uptodate. (2020). Johnson MR, Nash DR, Laird MR, Kiley RC, Martinez MA. Development and implementation of a pharmacist-managed, neonatal and pediatric, opioid-weaning protocol. J Pediatr Pharmacol Ther. 2014 Jul;19(3):165-73. doi: 10.5863/1551-6776-19.3.165. PMID: 25309146; PMCID: PMC4187529. Maguire, Denise J, PhD,R.N., C.N.L., Taylor, Susan, MSW,L.C.S.W.-C., C.M.A., Armstrong, K., PhD., Shaffer-Hudkins, E., Germain, A. M., M.D., Brooks, Sandra S,M.D., M.P.H., . . . Clark, L. (2016). Long-term outcomes of infants with neonatal abstinence syndrome: NN. Neonatal Network, 35(5), 277-286. doi:http://dx.doi.org/10.1891/0730-0832.35.5.277 Mangat, A. K., Schmölzer, G. M., & Kraft, W. K. (2019). Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS). Seminars in fetal & neonatal medicine, 24(2), 133–141. https://doi.org/10.1016/j.siny.2019.01.009 Merhar SL, Ounpraseuth S, Devlin LA, Poindexter BB, Young LW, Berkey SD, Crowley M, Czynski AJ, Kiefer AS, Whalen BL, Das A, Fuller JF, Higgins RD, Thombre V, Lester BM, Smith PB, Newman S, Sánchez PJ, Smith MC, Simon AE; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT NEONATAL RESEARCH NETWORK AND THE NIH ENVIRONMENTAL INFLUENCES ON CHILD HEALTH OUTCOMES (ECHO) PROGRAM INSTITUTIONAL DEVELOPMENT AWARDS STATES PEDIATRIC CLINICAL TRIALS NETWORK. Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2021 Mar;147(3):e2020017830. doi: 10.1542/peds.2020-017830. PMID: 33632932; PMCID: PMC7919109. Protecting Our Infants Act of 2015, H.R, 1462, 114th Cong. (2015-2016).  Sarka Lisonkova, Lindsay L. Richter, Joseph Ting, Giulia M. Muraca, Qi Wen, Azar Mehrabadi, Sheona Mitchell-Foster, Eugenia Oviedo-Joekes and Janet Lyons. Pediatrics August 2019, 144 (2) e20183664; DOI: https://doi.org/10.1542/peds.2018-3664 Siegler R., Saffran J., Eisenberg N., Deloache, J., & Gershoff, E. (2017). How Children Develop (5th ed.). NY, NY, USA: Macmillan Learning.  Stephen W. Patrick, Wanda D. Barfield, Brenda B. Poindexter and COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON SUBSTANCE USE AND PREVENTION. Neonatal Abstinence Withdrawal Syndrome. Pediatrics November 2020, 146 (5) e2020029074; DOI: https://doi.org/10.1542/peds.2020-029074 Patrick SW, Barfield WD, Poindexter BB; COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON SUBSTANCE USE AND PREVENTION. Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2020 Nov;146(5):e2020029074. doi: 10.1542/peds.2020-029074. PMID: 33106341. Zimmermann, U., Rudin, C., Duò, A. et al. Treatment of opioid withdrawal in neonates with morphine, phenobarbital, or chlorpromazine: a randomized double-blind trial. Eur J Pediatr 179, 141–149 (2020). https://doi.org/10.1007/s00431-019-03486-6

Full transcription available at http://heartsofgoldpodcast.com/ Megan created a storage area and a drive to stock the space with items needed for babies in the nursery with withdrawals from opioids. Megan has been a girl scout since Kindergarten. She is currently in the 10th grade. She has completed her Bronze and Silver awards. Megan is currently on the service team for her chapter counsel as a girl member. Megan has lots of interests outside of school. You will always see Megan in a theater production of competing in speech and debate. Her area she competes in is Original Oratory. Last year she spoke about perfectionism. Megan is part of the link crew at school which welcomes new students to the high school. She is also part of the high school theater company and will be playing the part of Nigel in the upcoming production of Matilda. She loves to read and journals when she can find the time. She has enjoyed being on her dance studios dance team for about 6 years and competed in group and solo competitions. She has also been part of the National Charity League, a mother daughter charity organization since the 7th grade. Last year she was the co-president of her class and this year she brings joy as the co-sunshine chair. She is also on the National Ticktockers Advisory board for National Charity League, Inc. Join our Facebook Community https://www.facebook.com/sherylmrobinson/ Instagram https://www.instagram.com/sherylmrobinson/?hl=en Please subscribe to Hearts of Gold on YouTube at https://www.youtube.com/sherylmrobinsonor on your favorite podcast app. Support future Hearts of Gold episodes at https://www.patreon.com/heartsofgold Editing by https://www.offthewalter.com/ Walter's YouTube channel is https://www.youtube.com/channel/UCt0wFZRVaOpUd_nXc_8-4yQ

Neonatal abstinence syndrome describes drug withdrawal signs in newborn babies after they have been exposed to certain medications in utero, typically opioids. Babies can go through withdrawal after birth when they are no longer being exposed to the substance in the maternal circulation via the placenta. Follow us on Instagram @yourekiddingrightdoctors Facebook: https://www.facebook.com/yourekiddingrightpod-107273607638323/ Our email is yourekiddingrightpod@gmail.com Make sure you hit SUBSCRIBE/FOLLOW so you don't miss out on any pearls of wisdom and RATE if you can to help other people find us! (This isn't individual medical advice, please use your own clinical judgement and local guidelines when caring for your patients)

What do adoptive and foster parents need to know about the impacts of prenatal exposure to opioids, Suboxone, and Methadone. What are the risks to a baby born with Neonatal Abstinence Syndrome or Neonatal Opioid Withdrawal Syndrome (NOWS)? We talk with Dr. Julian Davies, a pediatrician at the University of Washington’s Center for Adoption Medicine and their FASD and Prenatal Exposure Clinic.In this episode, we cover:What are opiates or opioids? What are the most common opiates that are being used during pregnancy? What are the most common non-opiate drugs that are being used by pregnant women? What are the common treatment medication/drugs given to those struggling with addiction who are trying to get off opioids? Methadone, Suboxone, and Subutex Are Methadone, Suboxone, and Subutex safe to use during pregnancy? What are the short- and long-term impacts on infants exposed to opiates? What are the short- and long-term impacts of infants exposed to Methadone in pregnancy? What are the short- and long-term impacts of infants exposed to Suboxone in pregnancy? Does the dosage of methadone or suboxone have an effect on the baby? What are the short- and long-term impacts of infants exposed to methamphetamines (meth) in pregnancy? What are the short- and long-term impacts of infants exposed to cocaine in pregnancy? What are the short- and long-term impacts of infants exposed to marijuana in pregnancy? Edible vs. smoking vs. vaping Does the timing of exposure in pregnancy affect the prognosis for the child? Is there a safer time for a fetus to be exposed to drugs in utero? Many parents believe that if the child is not born dependent or with drugs in their system that the prognosis is better. Or conversely, if the child is born dependent and has to go through withdrawals that they will suffer more impact from the in-utero drug exposure. Is this true? How serious is drug dependency and withdrawal for the infant? How is withdrawal treated in the infant? How is Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS) treated in babies born dependent? Families that adopt out of state are often concerned about how soon they can travel home with their baby if she has been born dependent and is going through withdrawal. How long does withdrawal in an infant born dependent last? If a baby tests positive for opiates is it possible to determine what drug the baby has been exposed to? Does the long-term prognosis matter depending on which drug? How do you foster attachment while baby is suffering through withdrawal? How common is it for women who use drugs during their pregnancy to also drink excessively during their pregnancy? One thing you hear a lot is that “early intervention is key” and that a baby’s brain can be rewired during the first couple of years with the right therapy. What exactly does that therapy entail? Where can you find it? What strategies should you be using at home with your child with a diagnosis of prenatal drug exposure? There are many similarities between drug exposure and trauma in how it affects children’s learning, behavior, etc. When a child has both of those challenges, is it possible to tell the difference on what is causing specific problems, and is the treatment different depending on the cause? Are children who are exposed prenatally at a greater risk for drug abuse as teens and adults if they were adopted and not raised in an environment that exposed them to drug use? What are the most common blood bornSupport the show (https://creatingafamily.org/donation/)

Join Katrina and her guest, Emily Hargrove, as they speak on The Papillion Center, a non-profit organization helping people from hard places. The center specializes in trauma, abuse, Fetal Alcohol Spectrum Disorder, Neonatal Abstinence Syndrome, & attachment issues

We discuss the prevalence of substance use in pregnancy, evaluation and management of the newborn, and discharge planning. We are joined by Kelly Mazzarella, DO, Assistant Professor of Neonatal-Perinatal Medicine at the University of Texas Southwestern Medical Center.

Did you know that NOWS is the new NAS? Learn more about the new AAP Clinical Report on Neonatal Opioid Withdrawal Syndrome with lead author Dr. Stephen Patrick. Dr. Patrick is the Director of the Vanderbilt Center for Child Health Policy, an Associate Professor of Pediatrics and Health Policy, and an attending neonatologist at Monroe Carol Jr. Children’s Hospital at Vanderbilt. In this episode, he teaches us about the approach to treating withdrawal in infants, the importance of keeping moms and babies together, and the need for destigmatizing addiction in healthcare.    Time Stamps 7:48 Case from Kashlak Children’s 8:38 Definition of neonatal opioid withdrawal syndrome  9:48 Clinical Presentation of NOWS 11:30 Scoring Systems 14:34 Importance of diagnosing NOWS 15:16 Opioid Crisis and Epidemiology 16:35 Risk Factors for developing NOWS 19:16 The role of structural racism and social determinants of health 21:05 Stigma of addiction 23:10 Building a therapeutic relationship 25:32 Breastfeeding 26:40 Toxicology testing 29:16 Structural racism  30:14 Non-pharmacologic management 31:58 Pharmacologic Management 35:16 Clinical course  37:40 Treatment and taper plan 40:20 Discharge planning 43:20 Outpatient Follow up 44:26 AAP Clinical Report Changes 46:46 Advocacy and Policy 47:14 Buprenorphine  50:18 Outro

Editor's Summary by Mary McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the January 12, 2021 issue

Episode 006: We are joined by Dr. Stephen Patrick to discuss the development and release of the new guidelines recently released by the American Academy of Pediatrics surrounding Neonatal Abstinence Syndrome. View the full recommendations here: https://pediatrics.aappublications.org/content/pediatrics/early/2020/10/10/peds.2020-029074.full.pdf No content or comments made in any TIPQC Healthy Mom Healthy Baby Podcast is intended to be comprehensive or medical advice. Neither healthcare providers nor patients should rely on TIPQC's Podcasts in determining the best practices for any particular patient.  Additionally, standards and practices in medicine change as new information and data become available and the individual medical professional should consult a variety of sources in making clinical decisions for individual patients. TIPQC undertakes no duty to update or revise any particular Podcast. It is the responsibility of the treating physician or health care professional, relying on independent experience and knowledge of the patient, to determine appropriate treatment.  

This episode covers neonatal abstinence syndrome (NAS).Written notes can be found at https://zerotofinals.com/paediatrics/neonatology/nas/ or in the neonatology section in the Zero to Finals paediatrics book.The audio in the episode was expertly edited by Harry Watchman.

Rev. Rebekah Fetzer calls into the show to (distantly) discuss how Susannah’s House is helping recovering opioid addicted moms & addressing Neonatal Abstinence Syndrome.

Welcome to PRN, your as needed dose of medical knowledge. Today Alana sits down with Dr. Jacinda Hays DO, a pediatrician and graduate from VCOM. In this episode, Dr. Hays continues are previous discussion involving maternal substance use disorders from a pediatrician's point of view. She sheds some light on the topic of neonatal abstinence syndrome and how to best manage these patients. If you are interested in learning more about the topics discussed in this episode please visit our instagram page, @prnmedpodcast . This is where you will also be able to stay in touch with what the team here at PRN is up to. As always, please be on the lookout for any future episodes!

Over 10 million Americans misused opioids in 2018, which includes over 800,000 heroin users. In 2016, there were more than 64,000 overdose deaths in the United States; in 2017 overdose deaths jumped to over 70,000. This is a number that continues to grow in at least 23 states. Opioid addiction is a crisis that defies age and sex differences; it defies county and state lines; up to now it has defied all attempts to curb this plague. No one questions that opioid addiction is a national crisis and it is not slacking off. Are the nation’s courts ready to take the lead in fighting this epidemic? What needs to be done and who should do it? Judge O. Duane Sloan with the Circuit Court in the Fourth Judicial District of Tennessee and Director Deborah Taylor Tate, head of the Administrative Office of the Courts for the Supreme Court of Tennessee and Co-Chair of the National Judicial Opioid Task Force, will discuss the recent Task Force Report and the efforts by the Nation’s Courts to take the lead in solving this countrywide crisis. Leave a comment or question about the episode at clapodcast@nacmnet.org. About the Speakers Judge O. Duane Sloan is a judge with the Circuit Court in the Fourth Judicial District of Tennessee. In 2019 the Chief Justice of the United States John G. Roberts awarded Judge Slone the National Center for State Courts’ William H. Rehnquist Award for Judicial Excellence, one of the highest judicial honors in the country. He has been recognized for his groundbreaking work helping people with opioid use disorder. Combatting the opioid epidemic is not just a professional commitment for Judge Slone. It’s personal. In 2011, Judge Slone and his wife, Gretchen, adopted an infant son who was born suffering from withdrawals as a result of his birth mother’s opioid use. Judge Sloan is also the 2018 recipient of the National Center for State Courts, “Distinguished Service” Award; the 2017 Tennessee Association of Recovery Court Professionals, “Judges Making a Difference” Award; and the 2016 Tennessee Public Health Association, “Visionary” Award, given for work in reducing incidences of births with Neonatal Abstinence Syndrome, including innovations in rural Tennessee to provide healthy housing and access to prenatal medical and behavioral health care. Deborah Taylor Tate is the Director of the Administrative Office of the Courts for the Supreme Court of Tennessee, the Conference of State Court Administrators and the Co-Chair of the National Judicial Opioid Task Force for state courts across the nation. She is a licensed attorney and Supreme Court Rule 31 mediator, who, in addition to her presently held office, also serves as Distinguished Senior Scholar at the Free State Foundation and Adjunct Lecturer at Vanderbilt University School of Nursing. She was twice-nominated to the Federal Communications Commission (FCC) by President George W. Bush and unanimously confirmed by the U.S. Senate in 2005. She served as Commissioner of the FCC until 2009, serving as chair of two Federal Joint Boards overseeing over $7B in advanced telecommunications services. At the time of her presidential appointment, Ms. Tate was serving as the chairman and director of the Tennessee Public Service Commission. Her previous state positions also include executive director of the Health Facilities Commission and as senior staff -assistant General Counsel for then-Governor, Senator Lamar Alexander and a Senior policy advisor to Governor Don Sundquist for mental/behavioral health. . Ms. Tate received both her undergraduate degree and Juris Doctorate (J.D.) from the University of Tennessee and attended Vanderbilt Law School.

Thieme Verlagamrican perinatly0:00Fri, 06 Mar 2020 00:00:00 GMT

Thieme Verlagamrican perinatly0:00Fri, 06 Mar 2020 00:00:00 GMT

This week, we talk about the variety of ways that children are affected by the opioid crisis. Also, Stephanie has a breakdown because it’s hard to accept the things you cannot change. In this episode, she sits down with Peter who describes the process of adopting three kids born with Neonatal Abstinence Syndrome; The Seattle Times’ Claudia Rowe who gives an overview of how this epidemic is impacting kids in the foster care system; and Kendra Cram and Ryan McGraw from Minford Elementary in Ohio, who have created a program that addresses social and emotional learning for kids who have been impacted by trauma.  Continue the conversation on your phone at https://flick.group/lastday. Last Day contains strong language, mature themes, and may not be appropriate for all listeners.    Transcriptions available shortly after air date at https://www.lemonadamedia.com/show/last-day/. Last Day is presented by www.newchapter.com. Claudia Rowe for the Seattle Times New York Times story on Minford Elementary Casper.com/lastday (promo code LASTDAY) hellofresh.com/LASTDAY80 Talkspace (promo code LASTDAY) Good Kids: How Not to Raise An A**hole An Arm and A Leg Dopey Learn more about your ad choices. Visit megaphone.fm/adchoices

This week, we talk about the variety of ways that children are affected by the opioid crisis. Also, Stephanie has a breakdown because it’s hard to accept the things you cannot change. In this episode, she sits down with Peter who describes the process of adopting three kids born with Neonatal Abstinence Syndrome; The Seattle Times’ Claudia Rowe who gives an overview of how this epidemic is impacting kids in the foster care system; and Kendra Cram and Ryan McGraw from Minford Elementary in Ohio, who have created a program that addresses social and emotional learning for kids who have been impacted by trauma.  Continue the conversation on your phone at https://flick.group/lastday. Last Day contains strong language, mature themes, and may not be appropriate for all listeners.  Transcriptions available shortly after air date at https://www.lemonadamedia.com/show/last-day/. Last Day is presented by www.newchapter.com. Claudia Rowe for the Seattle Times New York Times story on Minford Elementary Casper.com/lastday (promo code LASTDAY) hellofresh.com/LASTDAY80 Talkspace (promo code LASTDAY) Good Kids: How Not to Raise An A**hole An Arm and A Leg Dopey

Podcast: Medically Assisted Treatment for Opioid Use Disorder Part Two Evaluation and Credit: https://www.surveymonkey.com/r/MedChat5B Target Audience This activity is targeted toward internal medicine, family medicine and other specialties that treat patients with chronic pain. Statement of Need In 2017, overdose fatalities in Kentucky rose by 11% and Jefferson County had the most overdose deaths. It is critical for physicians and providers to be aware of the prevalence of illegal drugs and understand this culture - as legal prescribing guidelines / availability continues to be more restrictive and addicted patients may seek their "high" from illegal sources. Objectives At the conclusion of this offering, the participant will be able to: Discuss the effectiveness of medically assisted treatment (MAT) for opioid addictions. Describe the mechanisms of antagonist therapy. Understand the treatment guidelines for medically assisted therapy. Moderator James Jennings, M.D. Executive Medical Director, Adult Primary Care Director, Provider Wellbeing Norton Healthcare Speaker Jonathan W. Weeks, M.D. Maternal-Fetal Medicine Norton Children’s Maternal-Fetal Medicine Moderator, Speaker and Planner Disclosures The moderator, speaker and planners for this activity have no potential or actual conflicts of interest to disclose.   Commercial Support This activity is supported in part with a grant from Cardinal Health.   Physician Credits American Medical Association Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. HB1 / Prescribing Controlled Substances The Kentucky Board of Medical Licensure has approved the podcast Medically Assisted Treatment for Opioid Use Disorder - Part Two for.50 HB1 credit hours. ID# 0519-H.50-NHC6b. Date of Original Release | August 2019 Course Termination Date | December 2020 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org State Resources Listing of treatment centers / resources – FindHelpNowKY Kentucky State Police assistance in finding a treatment center – Angel Initiative Resources for Additional Study Hendrée E. Jones, Ph.D., et. al., “Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure”, New England Journal of Medicine 363: 24, pages 2320-2331 Quentin Johnson, “Case Study: County-Level Responses to the Opioid Crisis in Northern Kentucky”, The Journal of Law, Medicine & Ethics, 46 (2018): 382-386 Marc Galanter, “Combining medically assisted treatment and Twelve-Step programming: a perspective and Review”, The American Journal of Drug and Alcohol Abuse 2018, Vol. 44, No. 2, pages 151–159 Hefei Wen, PhD, et. al., “Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment”, Medical Care , Volume 55, Number 4, April 2017, pages 336-341 Harlan Matusow, M.A., et. al., “Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes”, Journal of Substance Abuse Treatment 44 (2013) 473–480

Medically Assisted Treatment for Opioid Use Disorder Part One Evaluation and Credit: https://www.surveymonkey.com/r/MedChat5A Target Audience This activity is targeted toward internal medicine, family medicine and other specialties that treat patients with chronic pain. Statement of Need In 2017, overdose fatalities in Kentucky rose by 11% and Jefferson County had the most overdose deaths. It is critical for physicians and providers to be aware of the prevalence of illegal drugs and understand this culture - as legal prescribing guidelines / availability continues to be more restrictive and addicted patients may seek their "high" from illegal sources. Objectives At the conclusion of this offering, the participant will be able to: Define medically assisted therapy (MAT) for opioid addiction. Identify the FDA-approved medications for opioid use disorder. Understand the indications, benefits and limitations of MAT; including the pregnant patient. Discuss the psychological effects of opiate withdrawal. Moderator James Jennings, M.D. Executive Medical Director, Adult Primary Care Director, Provider Wellbeing Norton Healthcare Speaker Jonathan W. Weeks, M.D. Maternal-Fetal Medicine Norton Children’s Maternal-Fetal Medicine Moderator, Speaker and Planner Disclosures The moderator, speaker and planners for this activity have no potential or actual conflicts of interest to disclose.   Commercial Support This activity is supported in part with a grant from Cardinal Health.   Physician Credits American Medical Association Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. HB1 / Prescribing Controlled Substances The Kentucky Board of Medical Licensure has approved the podcast Medically Assisted Treatment for Opioid Use Disorder - Part One for.50 HB1 credit hours. ID# 0519-H.50-NHC6b. Date of Original Release | August 2019 Course Termination Date | December 2020 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org State Resources Listing of treatment centers / resources – FindHelpNowKY Kentucky State Police assistance in finding a treatment center – Angel Initiative Resources for Additional Study Hendrée E. Jones, Ph.D., et. al., “Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure”, New England Journal of Medicine 363: 24, pages 2320-2331. Quentin Johnson, “Case Study: County-Level Responses to the Opioid Crisis in Northern Kentucky”, The Journal of Law, Medicine & Ethics, 46 (2018): 382-386. Marc Galanter, “Combining medically assisted treatment and Twelve-Step programming: a perspective and Review”, The American Journal of Drug and Alcohol Abuse 2018, Vol. 44, No. 2, pages 151–159. Hefei Wen, PhD, et. al., “Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment”, Medical Care , Volume 55, Number 4, April 2017, pages 336-341. Harlan Matusow, M.A., et. al., “Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes”, Journal of Substance Abuse Treatment 44 (2013) 473–480.

Dr. Thomas Strizich, a pediatrician at St. Peter's Hospital in Helena, Montana, talks about the effects of drug exposure to children in the womb and the trends in neonatal drug exposure in our state. For more information and other resources, visit our website at www.health.umt.edu/ccfwd. Audio Transcript

Podcast:  Addressing Opioid Use During Pregnancy   Evaluation and Credit: https://www.surveymonkey.com/r/MedChat4   Target Audience             This activity is targeted toward internal medicine, family medicine, pediatrics, obstetrics & gynecology, and other specialties that treat female patients of child-bearing years.   Statement of Need Kentucky's rate of infants born with NAS has increased significantly in the last decade and it has been noted that Kentucky's rate is higher than the national average. Providers should be current on the practice guidelines available to prevent NAS and minimize the effects when possible.   Objectives At the conclusion of this offering, the participant will be able to: Describe guidelines / requirements for identifying substance abuse in pregnant patients. Discuss the effects of opioids on maternal fetal health. Provide an overview of treatment options available. Define neonatal abstinence syndrome.  Understand the effects of NAS on the newborn. Moderator James Jennings, M.D. Executive Medical Director, Adult Primary Care Director, Provider Wellbeing Norton Healthcare   Speaker Jonathan W. Weeks, M.D. Maternal-Fetal Medicine Norton Children’s Maternal-Fetal Medicine     Moderator, Speaker and Planner Disclosures  The moderator, speaker and planners for this activity have no potential or actual conflicts of interest to disclose.   Commercial Support  This activity is supported in part with a grant from Cardinal Health.     Physician Credits American Medical Association Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.   Designation Norton Healthcare designates this enduring material for a maximum of .50AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.   HB1 / Prescribing Controlled Substances The Kentucky Board of Medical Licensure has approved the podcast Addressing Opioid Use During Pregnancyfor .50 HB1 credit hours. ID# 0519-H.50-NHC7b.   Date of Original Release |July 2019 Course Termination Date | December 2020 Contact Information |Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org   State Resources Listing of treatment centers / resources – FindHelpNowKY Kentucky State Police assistance in finding a treatment center – Angel Initiative    Resources for Additional Study    Bell, Jennifer, M.D., et. al., “Detoxification from opiate drugs during pregnancy,” American Journal of Obstetrics & Gynecology, September 2016,   Hodgins, Fran E., et. al. “Coordinating Outpatient Care for Pregnant and Postpartum Women with Opioid Use Disorder: Implications from the COACHH Program,” Maternal and Child Health Journal, (2019), 23:585 – 591.   Jansson, Lauren, M., M.D., et. al., “Neonatal Abstinence Syndrome,” Pediatric Clinics of North America, 66 (2019), pages 353 – 367.   Jones, Hendree E., PhD, et. al, “Analgesia, Opioids and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome,” Clinics in Perinatology, 46(2019), 349-366.   Klaman, Stacey, L., MPH, et. al., “Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of their Infants and Children: Literature Review to Support National Guidance,” Addict Medicine, Volume 11, Number 3, May/June 2017, pages 178 – 190.   Tran, Tran, H., et. al., “Methadone, Buphrenorphine, and Naltrexone for  the Treatment  of Opioid Use Disorder in Pregnant Women,”  Pharmacotherapy, 2017:37(7), pages 824 – 839.   Zedler, Barbara, K., et. al., “Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis fo safety in the mother, fetus and child,” Addiction, 111, pages 2115 – 2128.

The first wave of the opioid crisis began in 1991 when physicians began to overprescribe narcotic analgesics for pain. Eventually, addiction led to abuse and the fatality rates began to climb. In response, the US government cracked down on narcotic prescriptions--leading a surge in the price of medical grade opioids. By 2010, the cost of pharmacologic opiates was unaffordable, and users reverted back to the (now cheaper) alternative, heroin. 2013 marked the third wave of the opioid crisis, whereby synthetic, high-potency opiates like fentanyl and carfentanyl were being infused into other opiate products. With each wave, the world witnessed a spike in the number of opioid-related deaths, and thus far, our solutions have only led to new problems. But there is more to the opioid crisis than the effect of opioids on the voluntary user. In 2017, we released a show highlighting the clinical consequences and management of opioid dependence on infants born to mothers who had used opioids during their pregnancy. This week, we have remastered the 2017 program and included an update at the end. Produced by James E. Siegler. Music courtesy of Little Glass Men, Jason Shaw, and Chris Zabriskie. BrainWaves' podcasts and online content are intended for medical education only and should not be used for clinical decision making. Be sure to follow us on Twitter @brainwavesaudio for the latest updates to the podcast. REFERENCES McQueen K and Murphy-Oikonen J. Neonatal Abstinence Syndrome. The New England journal of medicine. 2016;375:2468-2479. Vlahov D, Des Jarlais DC, Goosby E, Hollinger PC, Lurie PG, Shriver MD and Strathdee SA. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. American journal of epidemiology. 2001;154:S70-7. Kocherlakota P. Neonatal abstinence syndrome. Pediatrics. 2014;134:e547-61. Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S and Alexander ER. Syringe exchange and risk of infection with hepatitis B and C viruses. American journal of epidemiology. 1999;149:203-13. Wodak A and Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006;41:777-813. Jarlenski M, Barry CL, Gollust S, Graves AJ, Kennedy-Hendricks A and Kozhimannil K. Polysubstance Use Among US Women of Reproductive Age Who Use Opioids for Nonmedical Reasons. Am J Public Health. 2017;107:1308-1310. Hudak ML, Tan RC, Committee On D, Committee On F, Newborn and American Academy of P. Neonatal drug withdrawal. Pediatrics. 2012;129:e540-60. Winkelman TNA, Villapiano N, Kozhimannil KB, Davis MM and Patrick SW. Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004-2014. Pediatrics. 2018;141. MacMillan KDL, Rendon CP, Verma K, Riblet N, Washer DB and Volpe Holmes A. Association of Rooming-in With Outcomes for Neonatal Abstinence Syndrome: A Systematic Review and Meta-analysis. JAMA Pediatr. 2018;172:345-351. Gomez-Pomar E and Finnegan LP. The Epidemic of Neonatal Abstinence Syndrome, Historical References of Its' Origins, Assessment, and Management. Front Pediatr. 2018;6:33.

What must pediatricians know to identify infants at risk for NAS, to treat them and to prepare moms to care for them at home? Dr. Emily Scott of Riley Children’s Health explains. Completion of all 8 Opioid Epidemic Podcast Series is Accredited for 2.0 AMA PRA Category 1 Credits™  For details: Https://ismanet.org/podcast  

What did you learn from this episode? Complete our short survey to let us know! Participants will be entered into a drawing to win a $25 Amazon gift card and some Poison Control swag. The winner will be announced on our next episode! SHOW NOTES: Summary:This episode will discuss a couple of special populations that have been affected by the opioid epidemic, addressing why it is necessary to look at these groups individually, and how each requires a different approach to achieve resolution of the problem. Further Reading: • MedlinePlus: Pregnancy and Opioids: https://medlineplus.gov/pregnancyandopioids.html• The American College of Obstetricians and Gynecologists: Opioid Use Disorder and Pregnancy FAQs: https://www.acog.org/Patients/FAQs/Opioid-Use-Disorder-and-Pregnancy• Prenatal Buprenorphine Versus Methadone Exposure and Neonatal Outcomes: Systematic Review and Meta-Analysis: https://academic.oup.com/aje/article/180/7/673/150018• National Institute on Drug Abuse: Treating Opioid Use Disorder During Pregnancy: https://www.drugabuse.gov/publications/treating-opioid-use-disorder-during-pregnancy/treating-opioid-use-disorder-during-pregnancy#ref• Public Health Surveillance of Prenatal Opioid Exposure in Mothers and Infants: https://pediatrics.aappublications.org/content/143/3/e20183801#ref-3• Jansson LM, Patrick SW. Neonatal Abstinence Syndrome. Pediatr Clin North Am. 2019 Apr;66(2):353-367. doi: 10.1016/j.pcl.2018.12.006. Review. https://www.ncbi.nlm.nih.gov/pubmed/30819342• Use of Codeine and Tramadol Products in Breastfeeding Women - Questions and Answers: https://www.fda.gov/Drugs/DrugSafety/ucm118113.htm• MotherToBaby: Fact Sheets: https://mothertobaby.org/fact-sheets-parent/• Substance Use During Pregnancy: https://www.guttmacher.org/state-policy/explore/substance-use-during-pregnancy• White Paper: Opioid Use, Misuse, and Overdose in Women: https://www.womenshealth.gov/files/documents/white-paper-opioid-508.pdf • Final Report: Opioid Use, Misuse, and Overdose in Women: https://www.womenshealth.gov/files/documents/final-report-opioid-508.pdf• HHS Mental Health and Addiction Insurance Help: https://www.hhs.gov/programs/topic-sites/mental-health-parity/mental-health-and-addiction-insurance-help/index.html• Parental Substance Use and the Child Welfare System: https://www.childwelfare.gov/pubPDFs/parentalsubabuse.pdf MUSIC CREDITS:Blue Dot Sessions - Upper RegistersScott Holmes - So HappyAudiobinger - Memory Lane For more POISON!, follow us on Twitter @NationalCapital, and subscribe to our newsletter on our website, www.poison.org. Support the National Capital Poison Center today at www.poison.org/donate

Dr Kris Reber visits the studio as we explore neonatal abstinence syndrome. An increasing number of babies are born to mothers with opioid-use disorder, which results in drug withdrawal. We cover the pathophysiology, symptoms, diagnosis, management and long-term outcomes of affected infants. We hope you can join us!

Although recent studies suggest that ‘rooming-in’ is associated with a decreased need for pharmacological treatment and length of stay for infants with neonatal abstinence syndrome (NAS), more research is required to determine the effective components and short-term and long-term NAS outcomes, including risks. Professor Alison Twycross talks to Dr Karen A McQueen, Lakehead University School of Nursing, Thunder Bay Ontario, Canada, about her recent commentary published by Evidence-Based Nursing: “‘Rooming-in’ could be an effective non-pharmacological treatment for infants with neonatal abstinence syndrome”. Read it for free for the next two months on the EBN website: https://ebn.bmj.com/content/21/4/110. Commentary on: MacMillan, KDL. et al. Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review with meta-analysis. JAMA Pediatr. 2018; 172; 345-351.

Neonatal Abstinence Syndrome (Sept 2009) by Oregon 1-800-222-1222

JAMA Pediatrics Editors' Summary by Dimitri Christakis, MD, MPH, Editor in Chief, and Frederick Rivara, MD, MPH, Editor of JAMA Open, for the August 6, 2018 issue

Podcast 58: Thailand boys and coach being rescued from a cave; the Third Epistle of John and the call to imitate good over evil; the excess power of the supreme court; and Neonatal Abstinence Syndrome induced by mothers with opioid addictions. Donate a patreon.com/kingdomofthelogos

Dr. Sandie Morgan and Dave Stachowiak talk to Chad Napier about the devastating impact drug use has had in his community and the dangers of synthetic drugs. Key Points West Virginia leads the nation in drug overdose National average is 19.8 per 100,000 but West Virginia is 52 per 100,000 Babies with Neonatal Abstinence Syndrome…

Dr. Sandie Morgan and Dave Stachowiak talk to Chad Napier about the devastating impact drug use has had in his community and the dangers of synthetic drugs. Key Points West Virginia leads the nation in drug overdose National average is 19.8 per 100,000 but West Virginia is 52 per 100,000 Babies with Neonatal Abstinence Syndrome…

The Educated Birth provides educational materials for birth workers to help in preparing the families they support. They represent the diverse families within our community while being both inclusive and informative. Cheyenne began The Educated Birth initially out of necessity for her clients. She soon discovered that many other birth workers were craving the need for what she was offering, and with that, she opened The Educated Birth shop.As the shop has grown, Cheyenne realized there was another need. While sitting in her OBGYN's office, she noticed that many of the magazines lacked diversity. She realized she wanted to create something that would touch families one-on-one providing them with information about pregnancy, birth, and parenthood. Cheyenne explains that "Everyday Birth Magazine is my love letter to the birth world, and also to the world in general. It says, "Whoever you are, you belong here."If you would like to connect with Cheyenne for doula support, design, photography or writing work head to her website.To learn more about or purchase your educational materials from The Educated Birth, click here.Interested in purchasing the Everyday Magazine, head over to the website where you can purchase both print and digital copies.Resources/Kickstarters: Richmond Doula Project | collective of full-spectrum doulas in Richmond, VARichmond Doulas | nonprofit organization of independent doulasMother May I? | documentaryConsent begins at birth"I thought I was crazy." One-third of women describe their births as traumatic. They're also saying they were shamed and silenced afterward when they tried to talk about how they were treated or how they feel."I didn't even know I was allowed to say no." This situation is urgent. Every day, more women and birthing people are failed by a system that hurts and traumatizes them--especially women of color and other marginalized groups.Original Body of Pain | documentaryFor pregnant women facing addiction, recovery is a family affair – rife with judgment, stigma and plenty of obstacles along the way. Original Body of Pain portrays the American opioid epidemic in an immersive, longitudinal fashion, following families stricken by addiction and Neonatal Abstinence Syndrome - when babies are born exposed to substances - for over a year of their lives.

Editor's Summary by Edward H. Livingston, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the April 3, 2018, issue

With the ongoing opioid crisis, not only those using opiates are affected. There has been an exponential rise in the incidence of neonatal abstinence syndrome--the multi-organ dysfunction experienced by newborns of mothers who are using opioid products and other substances. This week, we discuss the manifestations and ramifications of this disease, with a short commentary on implications of this global epidemic. Produced by James E. Siegler. Music by Little Glass Men, Jason Shaw, and Chris Zabriskie. Voiceover by Erika Mejia. BrainWaves' podcasts and online content are intended for medical education only and should not be used for clinical decision making. This is no excuse to give your irritable baby opiates in their applesauce. REFERENCES McQueen K and Murphy-Oikonen J. Neonatal Abstinence Syndrome. The New England journal of medicine. 2016;375:2468-2479. Vlahov D, Des Jarlais DC, Goosby E, Hollinger PC, Lurie PG, Shriver MD and Strathdee SA. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. American journal of epidemiology. 2001;154:S70-7. Kocherlakota P. Neonatal abstinence syndrome. Pediatrics. 2014;134:e547-61. Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S and Alexander ER. Syringe exchange and risk of infection with hepatitis B and C viruses. American journal of epidemiology. 1999;149:203-13. Wodak A and Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006;41:777-813. Jarlenski M, Barry CL, Gollust S, Graves AJ, Kennedy-Hendricks A and Kozhimannil K. Polysubstance Use Among US Women of Reproductive Age Who Use Opioids for Nonmedical Reasons. Am J Public Health. 2017;107:1308-1310. Hudak ML, Tan RC, Committee On D, Committee On F, Newborn and American Academy of P. Neonatal drug withdrawal. Pediatrics. 2012;129:e540-60.  

In this episode, a team of health care professionals share their insights about NAS and discuss signs and symptoms, treatment in the hospital. Neonatal Abstinence Syndrome occurs when an infant is born having been exposed to opiates through his or her mother, and experiences withdrawal after birth. (October 2017) http://www.moveforwardpt.com/Radio/Detail/neonatal-abstinence-syndrome-3

“Every 25 minutes, a baby is born addicted to opioids.” Staggering numbers for sure. Tara Sundem, co-founder of Hushabye Nursery, says she is on a mission to provide new ways to care for this fragile and explosive population which is rapidly increasing due to the Opioid Epidemic. She believes compassionate, professional care could change the course of their entire lives. Tara has been a neonatal nurse and caregiver for 24 years. She goes on to state that, “between the years 2008-2013, there has been a 235% increase in babies that are diagnosed with Neonatal Abstinence Syndrome”, and she feels the numbers are more likely even greater since 2013. Babies born with NAS suffer from a range of withdrawal symptoms that can include tremors, vomiting, loose stools, modeling of the skin, inability to sleep, inconsolable crying, sneezing, excessive yawning, and in some cases seizures, and need to be cared for differently. It is not uncommon for NAS babies to be given morphine to aid in their withdrawal. Because she has experienced the Opioid Epidemic as a caregiver to NAS babies, Tara discusses the importance of controlling Neonatal Abstinence Syndrome, how the drug withdrawals can be dangerous, and why the neonatal intensive care unit is not the right environment. According to Tara, babies with NAS are extremely hypersensitive, and when dealing with withdrawals, they need to be contained, not just rocked or cuddled. She created Hushabye Nursery, a recovery center that specializes in newborns withdrawing from substances that the mother has taken during the pregnancy, babies that will need to be medicated. It is staffed with both highly skilled professionals and volunteers that are trained to handle the drug withdrawals these babies are suffering from in a calming environment, away from all the lights and alarms of a neonatal unit. As her answer to the Opioid Epidemic, Tara Sundem, believes Hushabye Nursery will make the difference in these babies' lives, lowering seizures and allowing for attachment between the babies and caregivers. Tara remains positive and inspired through the knowledge that this is the right thing to do – fighting for this fragile population, providing the right care, and hoping to make a difference in their future. The post Saving Babies From The Opioid Epidemic appeared first on Inspired Media 360 TV - Inform | Inspire | Engage.

Neonatal abstinence syndrome (NAS) is a term for a group of problems a baby experiences when withdrawing from exposure to narcotics. It is estimated that 3 to 50 percent of newborn babies have been exposed to maternal drug use, depending on the population and area of the country.In this segment, Dr Steve Liao, MD, Washington University Neonatal-Perinatal medicine physician at St. Louis Children's Hospital, discusses NAS and when a pediatrician should refer to a specialist.

In this episode, Dr. Lauren Jansson discusses buprenorphine for neonatal abstinence syndrome, and Dr. Peter Creticos discusses a sublingual immunotherapy tablet for house dust mite allergies. Dr. Sadhna Vora hosts.

Virginia is facing an opioid crisis; over 1,400 people died from overdoses in the state in 2016. Addiction can negatively impact more than just the substance abuser, and a new collaborative in Virginia is looking to protect those that are most vulnerable: infants. The Virginia Neonatal Collaborative is a statewide group comprised of hospitals, clinicians, and other health care stakeholders dedicated to the health of mothers and babies. The group focuses on combatting issues such as Neonatal Abstinence Syndrome. Tune in today at noon to learn about the Commonwealth's efforts to lessen the impact of the opioid crisis on babies.

This week we review 1) Buprenorphine for the treatment of Neonatal Abstinence Syndrome: Kraft, Walter K., et al. "Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome." New England Journal of Medicine (2017). 2) Outcomes of FMT for C. difficile infections in IBD: Meighani, Alireza, et al. "Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease." Digestive Diseases and Sciences (2017): 1-6. 3) Vaccination During Pregnancy: Baxter, Roger, et al. "Effectiveness of vaccination during pregnancy to prevent infant pertussis." Pediatrics (2017): e20164091. 4) The Desire for Limb Amputation: Upadhyaya, Mihir A., and Henry A. Nasrallah. "The intense desire for healthy limb amputation: A dis-proprioceptive neuropsychiatric disorder." Annals of Clinical Psychiatry 29.2 (2017): 125-132. 5) A New Drug For ALS: Grady, Denise. "A Second Drug Is Approved to Treat A.L.S." The New York Times. The New York Times, 05 May 2017. Web. 07 May 2017. Welcome to TalkingMed, where we discuss current medical news. Contact: talkingmedpodcast@gmail.com Twitter: @TalkingMedPod   Song credit: Night Owl by Broke For Free from the Free Music Archive, used under CCBY Attribution License, modified from the original. Disclaimer: The information presented on this podcast are our own personal views, opinions, and research on the subject matter and do not represent those of our institution or our department. Anything discussed on this podcast should not be considered medical advice. Please contact a professional if you have any medical concerns. All content found on TalkingMed, including text, images, audio, or other formats were created for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have learned it from TalkingMed. Under no circumstances shall Vivek, Stephen, TalkingMed, any guests or contributors to the podcast or blog, or any employees, associates, or affiliates of TalkingMed be responsible for damages arising from use of the podcast or blog. This podcast or blog should not be used in any legal capacity whatsoever, including but not limited to establishing “standard of care” in a legal sense or as a basis for expert witness testimony. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast or blog. You hereby acknowledge that nothing contained on TalkingMed shall constitute financial, investment, legal and/or other professional advice and that no professional relationship of any kind is created between you and the TalkingMed. You hereby agree that you shall not make any financial, investment, legal and/or other decision based in whole or in part on anything contained on TalkingMed. Nothing on TalkingMed or included as a part of TalkingMed should be construed as an attempt to offer or render a medical opinion or otherwise engage in the practice of medicine. If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.  The content may contain health- or medical-related materials or discussions regarding sexually explicit disease states. If you find these materials offensive, you may not want to use this content.

Neonatal Abstinence Syndrome This week Womens Telehealth CEO, Tanya Mack hosts Dr. Meg Prado to talk about Neonatal Abstinence Syndrome. With the continued rise in rates of prescription medications, coupled with high incidence of illicit drug use, it is becoming all-too-common for babies to be born who are addicted to prescription and/or illicit drugs. Dr. […] The post Neonatal Abstinence Syndrome appeared first on Business RadioX ®.

Allison and Atish take a well-deserved break. Susan and Aaron run the show. With the opioid epidemic affecting newborns and pregnant women at an increasing rate, Aaron looks at how healthcare providers in the #457SEO and beyond are addressing what’s known as Neonatal Abstinence Syndrome. Chris Riddle drops by to talk to Susan and Aaron about his latest adventures in the natural beauty provided in the #457SEO. Also, an inside look at what makes a pledge drive tick.

Both in our region and nationally, the occurrence of Neonatal Abstinence Syndrome (NAS) has grown steadily over the past few years. Combining the expertise of neonatologists, pediatric clinical pharmacologists and a multidisciplinary team of caregivers into a single NAS program has put Children’s Mercy Kansas City in a unique position to explore new methods for treating this growing problem.Children's Mercy has developed a family-integrated process for infants at risk for Neonatal Abstinence Syndrome.The goal moving forward is to work with area community hospitals to prenatally identify infants at risk for NAS and provide education to the family before birth.Dr. Tamorah R. Lewis, a Neonatologist at Children’s Mercy Kansas City, is here to help families better understand NAS.

Although still illegal everywhere in the United States under federal law, Colorado and Washington have decided not to prosecute marijuana use or production at the state level. Despite this lack of enforcement, women who use marijuana during their pregnancies are being charged with child abuse shortly after giving birth. On this episode of Lawyer 2 Lawyer, hosts Bob Ambrogi and J. Craig Williams interview Sabrina Fendrick from the National Organization for the Reform of Marijuana Laws and Carla Lowe from Citizens Against Legalizing Marijuana. Together they discuss conflicting studies and beliefs regarding the benefits, harms, and prohibition of marijuana. Tune in to learn more about Fetal Alcohol Syndrome and Neonatal Abstinence Syndrome as well as the differences between THC, tobacco, and alcohol for pregnant women. Sabrina Fendrick currently serves as the Director of Strategic Partnerships for NORML the Washington DC-based National Organization for the Reform of Marijuana Laws. In 2010, she founded the NORML Women's Alliance and served as Director of Women's Outreach to develop multiple female-focused awareness campaigns to educate women, and empower them to speak out on behalf of progressive cannabis policies. Today Fendrick remains dedicated to increasing women's involvement throughout all aspects of the legalization movement, including parenting and child custody issues. Carla Lowe is the founder of Citizens Against Legalizing Marijuana (CALM). She has been a volunteer anti-drug activist since 1977. Carla co-founded Californians for Drug-Free Youth and Californians for Drug-Free Schools. In addition, she chaired the Nancy Reagan Speakers' Bureau of the National Federation of Parents for Drug-Free Youth. Lowe is a mother of five grown children, grandmother of nine, and former high-school teacher. Special thanks to our sponsor, Clio.

On July 1st a new law took effect in Tennessee that allows prosecutors to pursue criminal assault charges if the mother uses illegal drugs during pregnancy. Although it had widespread bipartisan support and is designed to fight Neonatal Abstinence Syndrome, some believe it to be an unconstitutional infraction on privacy, equal protection, and due process. On this episode of Lawyer 2 Lawyer, host J. Craig Williams interviews Tennessee House Representative Mike Carter and Legal Director for the American Civil Liberties Union of Tennessee Thomas Castelli. Together they discuss maximum penalties, the law's effect on demographics, and treatment based defenses to punishment. Tune in to hear why the Tennessee General Assembly believes this law is their only option and the reasons the ACLU is fighting it. Thomas H. Castelli is the Legal Director for the American Civil Liberties Union of Tennessee. Prior to joining the ACLU, he provided litigation counsel to businesses and law firms with Counsel on Call and was a founding partner with Castelli and Knox, LLP, a small general practice firm with an emphasis on employment discrimination and wrongful discharge. He also worked as an associate at Schulten, Ward and Turner, LLP as well as Sutherland, Asbill and Brennan, LLP, where he focused on employment, construction, bankruptcy and general business litigation. He is a native Tennessean who grew up in Murfreesboro. The Honorable Mike Carter is a House Representative in the Tennessee General Assembly. He is a life-long resident of Ooltewah, Tennessee and practiced law for twenty years before being appointed as Judge, now retired, in 1997 by then Governor Don Sundquist. In 2009, Mr. Carter served as Special Assistant to then County Mayor Claude Ramsey. In 2012, he ran unopposed as a State Representative to serve the people of the newly created 29th District of Tennessee. Carter serves on the House Civil Justice Committee, House Finance Ways and Means Committee, and the House Ethics Committee. He also serves on TACIR (Tennessee Advisory Commission on Intergovernmental Relations) and the House Judicial Oversight Panel. Special thanks to our sponsor, Clio.

Pediatric Grand Rounds with Matthew Grossman, MD Yale-New Haven Children's Hospital

Interview with Stephen W. Patrick, MD, MPH, MS, author of Neonatal Abstinence Syndrome and Associated Health Care Expenditures: United States, 2000-2009

When a pregnant woman uses addictive drugs (illicit or certain prescription drugs), she puts her baby at risk for a number of problems. Neonatal Abstinence Syndrome (NAS) is a term for a group of problems a baby experiences after birth …Read More »